Blood pressure management is central to the anesthetic care of patients with pregnancy hypertensive disorders, as uncontrolled hypertension increases the risk of complications such as stroke, placental abruption, and renal failure. Anesthesia providers must carefully control maternal blood pressure without causing hypotension, which can compromise uteroplacental perfusion.
First-line antihypertensive agents in these patients include labetalol, hydralazine, and nifedipine. The choice of agent depends on the clinical context and the patient’s response. Labetalol is commonly used due to its combined alpha- and beta-blocking effects, which reduce blood pressure without causing significant reflex tachycardia. Hydralazine, a direct vasodilator, can be used as an alternative or in combination with labetalol for more resistant cases of hypertension.
Continuous invasive blood pressure monitoring, typically via an arterial line, may be warranted in severe cases of preeclampsia or during cesarean section in patients with significant hemodynamic instability. This allows for real-time blood pressure management and the titration of vasopressors or antihypertensive agents as needed.
Magnesium sulfate
As mentioned previously, magnesium sulfate is widely used in patients with preeclampsia and eclampsia for the prevention and treatment of seizures. However, magnesium has important anesthetic implications. It acts as a vasodilator and may potentiate the effects of anesthetic agents and neuromuscular blockers, requiring careful titration of anesthetic drugs. Monitoring for signs of magnesium toxicity, such as respiratory depression, decreased reflexes, and cardiac arrhythmias, is critical during anesthetic care.
| Agent | Role | Key consideration |
|---|---|---|
| Labetalol | First-line antihypertensive; commonly used. | Combined alpha- and beta-blockade lowers pressure without significant reflex tachycardia. |
| Hydralazine | First-line antihypertensive; direct vasodilator. | Used as an alternative to labetalol or in combination with it for more resistant hypertension. |
| Nifedipine | First-line antihypertensive. | Choice among the three follows clinical context and the patient's response. |
| Magnesium sulfate | Prevention and treatment of seizures in preeclampsia and eclampsia; also acts as a vasodilator. | Potentiates anesthetic agents and neuromuscular blockers, so anesthetic drugs need careful titration; watch for respiratory depression, decreased reflexes, and arrhythmias. |
| Phenylephrine or ephedrine | Maintain hemodynamics during epidural placement in place of large-volume fluid preload. | Preeclamptic patients are prone to fluid overload and pulmonary edema, so fluids are used judiciously. |
| Phenylephrine or norepinephrine | Counter hypotension under spinal anesthesia, which would compromise placental perfusion and cause fetal distress. | Support pressure without provoking a dangerous hypertensive spike. |
| Remifentanil, beta-blockers, or calcium channel blockers | Blunt the pressor response to laryngoscopy and intubation when general anesthesia is unavoidable. | Induction can otherwise cause severe hypertensive surges; magnesium sulfate already on board may contribute some vasodilation and pressure control. |
